Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues

被引:0
|
作者
Falk Zakrzewski
Walter de Back
Martin Weigert
Torsten Wenke
Silke Zeugner
Robert Mantey
Christian Sperling
Katrin Friedrich
Ingo Roeder
Daniela Aust
Gustavo Baretton
Pia Hönscheid
机构
[1] University Hospital Carl Gustav Carus (UKD),Institute of Pathology
[2] TU Dresden,Institute for Medical Informatics and Biometry (IMB)
[3] Carl Gustav Carus Faculty of Medicine,Center for Information Services and High Performance Computing (ZIH)
[4] TU Dresden,National Center for Tumor Diseases (NCT)
[5] TU Dresden,undefined
[6] Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG),undefined
[7] Center for Systems Biology Dresden (CSBD),undefined
[8] ASGEN GmbH & Co. KG,undefined
[9] Partner Site Dresden,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The human epidermal growth factor receptor 2 (HER2) gene amplification status is a crucial marker for evaluating clinical therapies of breast or gastric cancer. We propose a deep learning-based pipeline for the detection, localization and classification of interphase nuclei depending on their HER2 gene amplification state in Fluorescence in situ hybridization (FISH) images. Our pipeline combines two RetinaNet-based object localization networks which are trained (1) to detect and classify interphase nuclei into distinct classes normal, low-grade and high-grade and (2) to detect and classify FISH signals into distinct classes HER2 or centromere of chromosome 17 (CEN17). By independently classifying each nucleus twice, the two-step pipeline provides both robustness and interpretability for the automated detection of the HER2 amplification status. The accuracy of our deep learning-based pipeline is on par with that of three pathologists and a set of 57 validation images containing several hundreds of nuclei are accurately classified. The automatic pipeline is a first step towards assisting pathologists in evaluating the HER2 status of tumors using FISH images, for analyzing FISH images in retrospective studies, and for optimizing the documentation of each tumor sample by automatically annotating and reporting of the HER2 gene amplification specificities.
引用
收藏
相关论文
共 50 条
  • [21] A Feasibility Study in The Automated Quantification of HER2 Gene Amplification in Breast Cancer Using Chromogenic In Situ Hybridization Whole Slide Images
    Wong, Willard
    Shakhawat, Hossain
    Hanna, Matthew
    Inoue, Takashi
    Stueben, Benjamin
    Ibrahim, Kareem
    Teplov, Alexei
    Edelweiss, Marcia
    Brogi, Edi
    Hameed, Meera
    Ross, Dara
    Yagi, Yukako
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 286 - 286
  • [22] Automated accelerated silver in-situ hybridization (SISH™) for detection of HER2 gene amplification in breast carcinoma
    Papouchado, B. G.
    Downs-Kelly, E.
    Pestic-Dragovich, L.
    Hood, S.
    Pettay, J. D.
    Myles, J.
    Loftus, M.
    Prescott, N.
    Grogan, T.
    Roche, P. C.
    McElhinny, A. S.
    Dabbs, D. J.
    Hanna, W. M.
    Dietel, M.
    Hicks, D. G.
    Alsabeh, R.
    Powell, W. C.
    Tubbs, R. R.
    LABORATORY INVESTIGATION, 2007, 87 : 44A - 44A
  • [23] Automated Silver-enhanced In Situ Hybridization for Evaluation of HER2 Gene Status in Breast Carcinoma: Comparison with Fluorescence In Situ Hybridization and Immunohistochemistry
    Sung, Woo Jung
    Park, Seok Ju
    Gu, Mi Jin
    Bae, Young Kyung
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (01) : 28 - 34
  • [24] Detection of HER-2/neu gene amplification by fluorescence in situ hybridization in human breast cancer
    Coupier, I
    Llorca, FP
    Perissel, B
    Tchirkov, A
    Malet, P
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 120 - 120
  • [25] The Correlation Between Dual-color Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization in Assessing HER2 Gene Amplification in Breast Cancer
    Pedersen, Marianne
    Rasmussen, Birgitte Bruun
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2009, 18 (02) : 96 - 102
  • [26] Performance of Automated Brightfield Dual Color In Situ Hybridization (ISH) for Detection of HER2 Gene Amplification in Breast Carcinoma
    Nitta, H.
    Hauss-Wegrzyniak, B.
    Lehrkamp, M.
    Murillo, A.
    Farrell, M.
    Kurosumi, M.
    Walk, E.
    Dietel, M.
    Penault-Llorca, F.
    Loftus, M.
    Wang, L.
    Pettay, J.
    Tubbs, R.
    Grogan, T.
    MODERN PATHOLOGY, 2009, 22 : 60A - 60A
  • [27] Performance of Automated Brightfield Dual Color In Situ Hybridization (ISH) for Detection of HER2 Gene Amplification in Breast Carcinoma
    Nitta, H.
    Hauss-Wegrzyniak, B.
    Lehrkamp, M.
    Murillo, A.
    Farrell, M.
    Kurosumi, M.
    Walk, E.
    Dietel, M.
    Penault-Llorca, F.
    Loftus, M.
    Wang, L.
    Pettay, J.
    Tubbs, R.
    Grogan, T.
    LABORATORY INVESTIGATION, 2009, 89 : 60A - 60A
  • [28] Comparison of Silver-Enhanced in situ Hybridization and Fluorescence in situ Hybridization for HER2 Gene Status in Breast Carcinomas
    Kang, Jun
    Kwon, Gui Young
    Lee, Young-Hee
    Gong, Gyungyub
    JOURNAL OF BREAST CANCER, 2009, 12 (04) : 235 - 240
  • [29] The correlation between dual colour chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER2 gene status
    Pedersen, Marianne
    Rasmussen, Birgitte Bruun
    APMIS, 2008, 116 (03) : 250 - 250
  • [30] HER2 Status in Gastric Adenocarcinomas Assessed by Immunohistochemistry, Automated Silver-Enhanced In Situ Hybridization and Fluorescence In Situ Hybridization
    Kim, Aeri
    Bae, Jung Min
    Kim, Se Won
    Gu, Mi Jin
    Bae, Young Kyung
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (05) : 493 - 501